Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02334904 : Comparison of Aripiprazole Versus Risperidone on Brain Morphology Using MRI
AgesMin: 12 Years Max: N/A
Inclusion Criteria:

- Male or female, aged 12+ years for healthy participants or participants with bipolar
disorder; or aged 15+ years for participants with non-affective psychosis.

- Recent admission to the Vancouver/Richmond Early Psychosis Intervention (EPI) program
related to first episode psychosis or first episode bipolar disorder;

- Participants being treated with an antipsychotic medication principally for psychosis
or for bipolar disorder.

- Participants taking aripiprazole must be taking a dose of at least 10mg/day for the
duration of the study.

- Participants must have received a minimum of 3 months of continuous antipsychotic
drug treatment with either aripiprazole or risperidone principally for psychosis or
bipolar disorder;

- Participants may be in- or outpatients.

- Participants able to give informed consent, or informed consent through legally
authorized representative.

Exclusion Criteria:

- Total life time exposure to the antipsychotic drug aripiprazole vs risperidone for
less than 3 months at time of consent.

- Previously diagnosed with diabetes mellitus, seizure disorders, mental retardation
(IQ < 70), or pregnancy (current or within 3 months postpartum)

- Participants who have been treated/are currently being treated with mood stabilizers
(paroxetine, lithium, or valproic acid). Prior or concurrent use of Selective
Serotonin Reuptake Inhibitor antidepressants (other than paroxetine) is acceptable..

- Received antipsychotic polypharmacy (treatment with more than one antipsychotic drug)

- Participants who are not able to fluently communicate in English.

- Contraindicated for MRI scan (i.e., has had major surgery in the last 6 months,
morbid obesity, claustrophobia, and/or has metal in their bodies from a surgical
intervention or working in metalwork, or is unsure if metal is present in their
bodies, etc.)
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557